Roser Ferrer

1.7k total citations
99 papers, 1.1k citations indexed

About

Roser Ferrer is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Roser Ferrer has authored 99 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Roser Ferrer's work include Liver Disease Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (12 papers) and Hormonal and reproductive studies (11 papers). Roser Ferrer is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (12 papers) and Hormonal and reproductive studies (11 papers). Roser Ferrer collaborates with scholars based in Spain, Palestinian Territory and United States. Roser Ferrer's co-authors include Albert Lecube, Juan Antonio Baena‐Fustegueras, Eva Pardina, Julia Peinado‐Onsurbe, José Manuel Fort, Roberto Catalán, Vı́ctor Vargas, Joaquín Rivero Déniz, Jacques Planas and Juan Moróte and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Roser Ferrer

90 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roser Ferrer 374 302 241 235 171 99 1.1k
Mikael Knutsson 425 1.1× 270 0.9× 175 0.7× 134 0.6× 217 1.3× 40 1.3k
Sudha S. Shankar 467 1.2× 486 1.6× 587 2.4× 301 1.3× 179 1.0× 40 1.7k
In Kyung Sung 589 1.6× 335 1.1× 244 1.0× 91 0.4× 516 3.0× 80 1.6k
Yanhua Chen 264 0.7× 280 0.9× 107 0.4× 70 0.3× 218 1.3× 86 1.2k
Kentaro Watanabe 219 0.6× 259 0.9× 258 1.1× 122 0.5× 148 0.9× 132 989
Cansel Türkay 288 0.8× 251 0.8× 68 0.3× 160 0.7× 84 0.5× 50 825
Giovanni Tortorella 184 0.5× 217 0.7× 433 1.8× 142 0.6× 203 1.2× 57 1.4k
Jan Borovicka 403 1.1× 631 2.1× 102 0.4× 232 1.0× 263 1.5× 78 1.7k
Ömer Özcan 173 0.5× 298 1.0× 275 1.1× 224 1.0× 133 0.8× 65 1.4k
Valorie L. Chiasson 162 0.4× 191 0.6× 146 0.6× 122 0.5× 84 0.5× 31 1.7k

Countries citing papers authored by Roser Ferrer

Since Specialization
Citations

This map shows the geographic impact of Roser Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roser Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roser Ferrer more than expected).

Fields of papers citing papers by Roser Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roser Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roser Ferrer. The network helps show where Roser Ferrer may publish in the future.

Co-authorship network of co-authors of Roser Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Roser Ferrer. A scholar is included among the top collaborators of Roser Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roser Ferrer. Roser Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrer, Roser, et al.. (2025). Analytical Interference of Exemestane With Androstenedione Immunoassays. Annals of Laboratory Medicine. 45(4). 410–419. 1 indexed citations
2.
4.
Boraíta, Araceli, Gonzalo Saco‐Ledo, Lidia B. Alejo, et al.. (2025). Physical exercise intervention in glycogen storage disease IIIa: Feasibility and multisystem benefits. Experimental Physiology. 111(1). 153–166.
5.
Garcı́a, Javier Garcı́a, A. Celma, Juan Moróte, et al.. (2024). Association of the rs1042522 SNP with prostate cancer risk: a study of cancer tissues, primary tumor cultures, and serum samples from a Spanish Caucasian population. Frontiers in Oncology. 14. 1398411–1398411. 2 indexed citations
6.
Casteràs, Anna, et al.. (2024). Pre-Surgery Cortisol Levels as Biomarker of Evolution after Bariatric Surgery: Weight Loss and Weight Regain. Journal of Clinical Medicine. 13(17). 5146–5146. 3 indexed citations
7.
Sánchez-Iglesias, José Luís, Lucas Minig, Víctor Lago, et al.. (2024). Procalcitonin and C‐reactive protein as early markers of anastomotic leakage in intestinal resections for advanced ovarian cancer (EDMOCS). Acta Obstetricia Et Gynecologica Scandinavica. 103(7). 1302–1310. 2 indexed citations
8.
Valenzuela, Pedro L., Alfredo Santalla, Lidia B. Alejo, et al.. (2024). Acute ketone supplementation in the absence of muscle glycogen utilization: Insights from McArdle disease. Clinical Nutrition. 43(3). 692–700. 4 indexed citations
9.
Vila, Marta, David Tabernero, Josep Gregori, et al.. (2024). Genotyping Hepatitis B virus by Next-Generation Sequencing: Detection of Mixed Infections and Analysis of Sequence Conservation. International Journal of Molecular Sciences. 25(10). 5481–5481. 2 indexed citations
10.
Vergara, Ander, Francisco Gonçalves, Sheila Bermejo, et al.. (2024). SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice. Frontiers in Pharmacology. 15. 1415879–1415879. 6 indexed citations
11.
Malhotra, Sunny, Luciana Midaglia, Nikolaos A. Patsopoulos, et al.. (2023). TheCYP24A1gene variant rs2762943 is associated with low serum 1,25‐dihydroxyvitamin D levels in multiple sclerosis patients. European Journal of Neurology. 30(8). 2401–2410. 2 indexed citations
12.
Ruiz‐Rodríguez, Juan Carlos, Luis Chiscano‐Camón, Alejandro Cortes, et al.. (2023). Use of Biomarkers to Improve 28-Day Mortality Stratification in Patients with Sepsis and SOFA ≤ 6. Biomedicines. 11(8). 2149–2149. 10 indexed citations
13.
Riveiro‐Barciela, Mar, David Tabernero, Adriana Palom, et al.. (2022). Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients: a Promising Marker of Infection Follow-Up. Microbiology Spectrum. 10(2). e0214921–e0214921. 6 indexed citations
14.
Tabernero, David, Josep Gregori, Josep Quer, et al.. (2022). Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients. Biomedicines. 10(5). 1194–1194. 2 indexed citations
15.
Cobbaert, Christa M., Raymond Noordam, Nannette Brouwer, et al.. (2022). Indirect determination of biochemistry reference intervals using outpatient data. PLoS ONE. 17(5). e0268522–e0268522. 4 indexed citations
16.
Weber, Stephen G., Martin Klammer, M. Hernández, et al.. (2022). Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2. Diagnostics. 12(4). 886–886. 11 indexed citations
17.
Garcia-Fernandez, Alba-Estela, Albert Blanco‐Grau, Christa M. Cobbaert, et al.. (2022). Harmonization of indirect reference intervals calculation by the Bhattacharya method. Clinical Chemistry and Laboratory Medicine (CCLM). 61(2). 266–274.
19.
Biagetti, Betina, José Raúl Herance, Roser Ferrer, et al.. (2019). Metabolic Fingerprint of Acromegaly and Its Potential Usefulness in Clinical Practice. Journal of Clinical Medicine. 8(10). 1549–1549. 11 indexed citations
20.
Neukum, Christoph, Pablo Jiménez‐Gavilán, Cristina Liñán Baena, et al.. (2004). Consideraciones sobre el funcionamiento hidrogeológico y la vulnerabilidad a la contaminación de la Sierra de las Nieves (Málaga) a partir de un ensayo de trazador en condiciones de estiaje. Geogaceta. 143–146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026